what we do
Dedicated to the development of novel ancillary devices through strategic partnerships to enhance transcatheter treatments for valvular and other structural cardiac diseases.
Primary Services for our Partners
Development of a full array of supportive devices to enhance transcatheter and minimally invasive structural cardiac procedures.
Improve procedural safety, efficacy, and efficiency.
Reduce overall procedural cost.
Broad dissemination of appropriate and safe use of new technologies through educational programs.
Offer consultative services for cutting edge approaches in the treatment of valvular and structural cardiac diseases
Prior and Current Efforts
Under contractual agreements with:
Development of a novel balloon valvuloplasty catheter for AS
Development of the TAVR Safari GW partnering with Lake Regions Medical
Novel 3-component transeptal system, intellectual property sales to Baylis Medical
Novel double-lumen diagnostic catheters partnering with Teleflex Medical
Novel temporary pacing lead under early stage development partnering with Nextern Inc